カテゴリ： Infiniti Research TechNavio, 世界, 医療/バイオ

エピジェネティクスのグローバル市場2023～2027：腫瘍、非腫瘍

■ 英語タイトル：Global Epigenetics Market 2023-2027

調査会社Technavio社が発行したリサーチレポート（データ管理コード：IRTNTR75055-23）■ 発行会社/調査会社：Technavio
■ 商品コード：IRTNTR75055-23
■ 発行日：2023年3月8日
■ 調査対象地域：北米、ヨーロッパ、アジア、その他地域
■ 産業分野：生命科学
■ ページ数：約120
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥608,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[エピジェネティクスのグローバル市場2023～2027：腫瘍、非腫瘍]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Technavio社の本報告書では、世界のエピジェネティクス市場規模が2022年から2027年の間に1148.2百万ドルまで上昇すると推定しており、予測期間中にCAGR 14.06%成長する見込みです。本書ではエピジェネティクスの世界市場を調査し、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、用途別（腫瘍、非腫瘍）分析、製品別（試薬、キット、その他）分析、地域別（北米、ヨーロッパ、アジア、その他地域、アメリカ、ドイツ、中国、イギリス、カナダ）分析、顧客状況、推進要因・課題・動向、企業状況、企業分析などの内容をまとめました。なお、Abcam plc, Active Motif Inc., Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio Techne Corp., BioVision Inc., CellCentric Ltd., Enzo Biochem Inc., EpiGentek Group Inc., F. Hoffmann La Roche Ltd., Hologic Inc., Illumina Inc., Merck KGaA, New England Biolabs Inc., Pacific Biosciences of California Inc., Perkin Elmer Inc., Promega Corp., QIAGEN NV, Thermo Fisher Scientific Inc., Zymo Research Corp.などの関連企業情報が収録されています。
・エグゼクティブサマリー
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析
・世界のエピジェネティクス市場規模：用途別
- 腫瘍における市場規模
- 非腫瘍における市場規模
・世界のエピジェネティクス市場規模：製品別
- 試薬の市場規模
- キットの市場規模
- その他製品の市場規模
・顧客状況
・世界のエピジェネティクス市場規模：地域別
- 北米のエピジェネティクス市場規模
- ヨーロッパのエピジェネティクス市場規模
- アジアのエピジェネティクス市場規模
- その他地域のエピジェネティクス市場規模
- アメリカのエピジェネティクス市場規模
- ドイツのエピジェネティクス市場規模
- 中国のエピジェネティクス市場規模
- イギリスのエピジェネティクス市場規模
- カナダのエピジェネティクス市場規模
・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益・価格・競争・プロモーションなどの主なパラメーターを分析することにより、複数の情報源からのデータを調査・統合・統括することで、エピジェネティクス市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、多様な市場の側面を提示します。これらのデータは包括的​​且つ信頼性が高く、一次・二次の広範な調査の結果です。Technavio社の市場調査資料は、正確なエピジェネティクス市場の成長を予測するため、定性的・定量的調査により徹底的な競合状況、詳細に及ぶベンダー選定＆分析を提供します。

エピジェネティクスの世界市場 2023-2027

Technavio社はエピジェネティクス市場をモニターしており、2022年から2027年にかけて1,148.2百万ドルの成長が予測され、予測期間中のCAGRは14.06%で加速すると予測しています。当レポートでは、エピジェネティクス市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。

当レポートでは、現在の市場シナリオ、最新動向や促進要因、市場環境全体に関する最新分析を提供しています。非腫瘍性疾患におけるエピジェネティック・アプリケーションの増加、CVDの有病率の増加、戦略的提携やM&Aの増加などが市場を牽引しています。

Technavio社のエピジェネティクス市場は以下のようにセグメント化されています：

・用途別：
– がん
– 非がん

・製品別：
– 試薬
– キット
– その他

・地域別：
– 北米
– ヨーロッパ
– アジア
– その他の地域（ROW）

本調査では、今後数年間のエピジェネティクス市場の成長を促進する主な理由の一つとして、ライフサイエンス産業における技術的進歩を挙げています。また、ゲノムプロジェクトの増加や最近の開発件数の増加は、市場の大きな需要につながるでしょう。

Technavio社は、主要パラメーターの分析による複数の情報源からのデータの調査、合成、集計の方法により、市場の詳細な姿を提示します。

エピジェネティクス市場に関する弊社のレポートは以下の分野をカバーしています：
– エピジェネティクス市場のサイジング
– エピジェネティクス市場の予測
– エピジェネティクス市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Abcam plc, Active Motif Inc., Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio Techne Corp., BioVision Inc., CellCentric Ltd., Enzo Biochem Inc., EpiGentek Group Inc., F. Hoffmann La Roche Ltd., Hologic Inc., Illumina Inc., Merck KGaA, New England Biolabs Inc., Pacific Biosciences of California Inc., Perkin Elmer Inc., Promega Corp., QIAGEN NV, Thermo Fisher Scientific Inc., and Zymo Research Corpなどの企業情報が含まれています。また、エピジェネティクス市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global epigenetics market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global epigenetics market 2017 – 2021 ($ million)
o 4.2 Application Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.3 Product Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application – Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Oncology – Market size and forecast 2022-2027
o Exhibit 34: Chart on Oncology – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Oncology – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Oncology – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Oncology – Year-over-year growth 2022-2027 (%)
o 6.4 Non-oncology – Market size and forecast 2022-2027
o Exhibit 38: Chart on Non-oncology – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Non-oncology – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Non-oncology – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Non-oncology – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Application
o Exhibit 42: Market opportunity by Application ($ million)
o Exhibit 43: Data Table on Market opportunity by Application ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 44: Chart on Product – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Product – Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 46: Chart on Comparison by Product
o Exhibit 47: Data Table on Comparison by Product
o 7.3 Reagents – Market size and forecast 2022-2027
o Exhibit 48: Chart on Reagents – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Reagents – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Reagents – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Reagents – Year-over-year growth 2022-2027 (%)
o 7.4 Kits – Market size and forecast 2022-2027
o Exhibit 52: Chart on Kits – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Kits – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Kits – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Kits – Year-over-year growth 2022-2027 (%)
o 7.5 Others – Market size and forecast 2022-2027
o Exhibit 56: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Product
o Exhibit 60: Market opportunity by Product ($ million)
o Exhibit 61: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 67: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 83: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 91: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 Canada – Market size and forecast 2022-2027
o Exhibit 95: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 99: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Abcam plc
o Exhibit 111: Abcam plc – Overview
o Exhibit 112: Abcam plc – Product / Service
o Exhibit 113: Abcam plc – Key news
o Exhibit 114: Abcam plc – Key offerings
o 12.4 Active Motif Inc.
o Exhibit 115: Active Motif Inc. – Overview
o Exhibit 116: Active Motif Inc. – Product / Service
o Exhibit 117: Active Motif Inc. – Key offerings
o 12.5 Agilent Technologies Inc.
o Exhibit 118: Agilent Technologies Inc. – Overview
o Exhibit 119: Agilent Technologies Inc. – Business segments
o Exhibit 120: Agilent Technologies Inc. – Key news
o Exhibit 121: Agilent Technologies Inc. – Key offerings
o Exhibit 122: Agilent Technologies Inc. – Segment focus
o 12.6 Bio Rad Laboratories Inc.
o Exhibit 123: Bio Rad Laboratories Inc. – Overview
o Exhibit 124: Bio Rad Laboratories Inc. – Business segments
o Exhibit 125: Bio Rad Laboratories Inc. – Key news
o Exhibit 126: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 127: Bio Rad Laboratories Inc. – Segment focus
o 12.7 BioVision Inc.
o Exhibit 128: BioVision Inc. – Overview
o Exhibit 129: BioVision Inc. – Product / Service
o Exhibit 130: BioVision Inc. – Key offerings
o 12.8 EpiGentek Group Inc.
o Exhibit 131: EpiGentek Group Inc. – Overview
o Exhibit 132: EpiGentek Group Inc. – Product / Service
o Exhibit 133: EpiGentek Group Inc. – Key offerings
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 134: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 135: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 136: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 137: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 138: F. Hoffmann La Roche Ltd. – Segment focus
o 12.10 Hologic Inc.
o Exhibit 139: Hologic Inc. – Overview
o Exhibit 140: Hologic Inc. – Business segments
o Exhibit 141: Hologic Inc. – Key news
o Exhibit 142: Hologic Inc. – Key offerings
o Exhibit 143: Hologic Inc. – Segment focus
o 12.11 Illumina Inc.
o Exhibit 144: Illumina Inc. – Overview
o Exhibit 145: Illumina Inc. – Business segments
o Exhibit 146: Illumina Inc. – Key news
o Exhibit 147: Illumina Inc. – Key offerings
o Exhibit 148: Illumina Inc. – Segment focus
o 12.12 Merck KGaA
o Exhibit 149: Merck KGaA – Overview
o Exhibit 150: Merck KGaA – Business segments
o Exhibit 151: Merck KGaA – Key news
o Exhibit 152: Merck KGaA – Key offerings
o Exhibit 153: Merck KGaA – Segment focus
o 12.13 New England Biolabs Inc.
o Exhibit 154: New England Biolabs Inc. – Overview
o Exhibit 155: New England Biolabs Inc. – Product / Service
o Exhibit 156: New England Biolabs Inc. – Key news
o Exhibit 157: New England Biolabs Inc. – Key offerings
o 12.14 Perkin Elmer Inc.
o Exhibit 158: Perkin Elmer Inc. – Overview
o Exhibit 159: Perkin Elmer Inc. – Business segments
o Exhibit 160: Perkin Elmer Inc. – Key news
o Exhibit 161: Perkin Elmer Inc. – Key offerings
o Exhibit 162: Perkin Elmer Inc. – Segment focus
o 12.15 QIAGEN NV
o Exhibit 163: QIAGEN NV – Overview
o Exhibit 164: QIAGEN NV – Product / Service
o Exhibit 165: QIAGEN NV – Key news
o Exhibit 166: QIAGEN NV – Key offerings
o 12.16 Thermo Fisher Scientific Inc.
o Exhibit 167: Thermo Fisher Scientific Inc. – Overview
o Exhibit 168: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 169: Thermo Fisher Scientific Inc. – Key news
o Exhibit 170: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 171: Thermo Fisher Scientific Inc. – Segment focus
o 12.17 Zymo Research Corp.
o Exhibit 172: Zymo Research Corp. – Overview
o Exhibit 173: Zymo Research Corp. – Product / Service
o Exhibit 174: Zymo Research Corp. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 175: Inclusions checklist
o Exhibit 176: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 177: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 178: Research methodology
o Exhibit 179: Validation techniques employed for market sizing
o Exhibit 180: Information sources
o 13.5 List of abbreviations
o Exhibit 181: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global epigenetics market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Application – Market share 2022-2027 (%)
Exhibits31: Data Table on Application – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Oncology – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oncology – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oncology – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oncology – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Non-oncology – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Non-oncology – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Non-oncology – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Non-oncology – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Application ($ million)
Exhibits43: Data Table on Market opportunity by Application ($ million)
Exhibits44: Chart on Product – Market share 2022-2027 (%)
Exhibits45: Data Table on Product – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Product
Exhibits47: Data Table on Comparison by Product
Exhibits48: Chart on Reagents – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Reagents – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Reagents – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Reagents – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Kits – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Kits – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Kits – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Kits – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Product ($ million)
Exhibits61: Data Table on Market opportunity by Product ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Abcam plc – Overview
Exhibits112: Abcam plc – Product / Service
Exhibits113: Abcam plc – Key news
Exhibits114: Abcam plc – Key offerings
Exhibits115: Active Motif Inc. – Overview
Exhibits116: Active Motif Inc. – Product / Service
Exhibits117: Active Motif Inc. – Key offerings
Exhibits118: Agilent Technologies Inc. – Overview
Exhibits119: Agilent Technologies Inc. – Business segments
Exhibits120: Agilent Technologies Inc. – Key news
Exhibits121: Agilent Technologies Inc. – Key offerings
Exhibits122: Agilent Technologies Inc. – Segment focus
Exhibits123: Bio Rad Laboratories Inc. – Overview
Exhibits124: Bio Rad Laboratories Inc. – Business segments
Exhibits125: Bio Rad Laboratories Inc. – Key news
Exhibits126: Bio Rad Laboratories Inc. – Key offerings
Exhibits127: Bio Rad Laboratories Inc. – Segment focus
Exhibits128: BioVision Inc. – Overview
Exhibits129: BioVision Inc. – Product / Service
Exhibits130: BioVision Inc. – Key offerings
Exhibits131: EpiGentek Group Inc. – Overview
Exhibits132: EpiGentek Group Inc. – Product / Service
Exhibits133: EpiGentek Group Inc. – Key offerings
Exhibits134: F. Hoffmann La Roche Ltd. – Overview
Exhibits135: F. Hoffmann La Roche Ltd. – Business segments
Exhibits136: F. Hoffmann La Roche Ltd. – Key news
Exhibits137: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits138: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits139: Hologic Inc. – Overview
Exhibits140: Hologic Inc. – Business segments
Exhibits141: Hologic Inc. – Key news
Exhibits142: Hologic Inc. – Key offerings
Exhibits143: Hologic Inc. – Segment focus
Exhibits144: Illumina Inc. – Overview
Exhibits145: Illumina Inc. – Business segments
Exhibits146: Illumina Inc. – Key news
Exhibits147: Illumina Inc. – Key offerings
Exhibits148: Illumina Inc. – Segment focus
Exhibits149: Merck KGaA – Overview
Exhibits150: Merck KGaA – Business segments
Exhibits151: Merck KGaA – Key news
Exhibits152: Merck KGaA – Key offerings
Exhibits153: Merck KGaA – Segment focus
Exhibits154: New England Biolabs Inc. – Overview
Exhibits155: New England Biolabs Inc. – Product / Service
Exhibits156: New England Biolabs Inc. – Key news
Exhibits157: New England Biolabs Inc. – Key offerings
Exhibits158: Perkin Elmer Inc. – Overview
Exhibits159: Perkin Elmer Inc. – Business segments
Exhibits160: Perkin Elmer Inc. – Key news
Exhibits161: Perkin Elmer Inc. – Key offerings
Exhibits162: Perkin Elmer Inc. – Segment focus
Exhibits163: QIAGEN NV – Overview
Exhibits164: QIAGEN NV – Product / Service
Exhibits165: QIAGEN NV – Key news
Exhibits166: QIAGEN NV – Key offerings
Exhibits167: Thermo Fisher Scientific Inc. – Overview
Exhibits168: Thermo Fisher Scientific Inc. – Business segments
Exhibits169: Thermo Fisher Scientific Inc. – Key news
Exhibits170: Thermo Fisher Scientific Inc. – Key offerings
Exhibits171: Thermo Fisher Scientific Inc. – Segment focus
Exhibits172: Zymo Research Corp. – Overview
Exhibits173: Zymo Research Corp. – Product / Service
Exhibits174: Zymo Research Corp. – Key offerings
Exhibits175: Inclusions checklist
Exhibits176: Exclusions checklist
Exhibits177: Currency conversion rates for US$
Exhibits178: Research methodology
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Information sources
Exhibits181: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 電子顕微鏡のグローバル市場2023-2027：半導体、ライフサイエンス、材料科学、ナノテクノロジー
  • 半導体パッケージング材料のグローバル市場2023-2027：有機基板、リードフレーム、ボンディングワイヤ、セラミックパッケージ、その他
  • 携帯式浄水器の世界市場2023～2027
  • 自律型水中探査機（AUV）のグローバル市場2023-2027：通信、衝突回避、ナビゲーション、推進、イメージング
  • スタチンのグローバル市場2023-2027：病院、診療所、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IRTNTR75055-23 )"エピジェネティクスのグローバル市場2023～2027：腫瘍、非腫瘍" (英文：Global Epigenetics Market 2023-2027)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。